259 related articles for article (PubMed ID: 10392668)
1. Adverse skin reactions to low molecular weight heparins: frequency, management and prevention.
Wütschert R; Piletta P; Bounameaux H
Drug Saf; 1999 Jun; 20(6):515-25. PubMed ID: 10392668
[TBL] [Abstract][Full Text] [Related]
2. Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: a prospective study.
Grassegger A; Fritsch P; Reider N
Dermatol Surg; 2001 Jan; 27(1):47-52. PubMed ID: 11231243
[TBL] [Abstract][Full Text] [Related]
3. [A study of 19 cases of allergy to heparins with positive skin testing].
Phan C; Vial-Dupuy A; Autegarden JE; Amsler E; Gaouar H; Abuaf N; Pecquet C; Francès C; Soria A
Ann Dermatol Venereol; 2014 Jan; 141(1):23-9. PubMed ID: 24461090
[TBL] [Abstract][Full Text] [Related]
4. Delayed-type hypersensitivity skin reactions caused by subcutaneous unfractionated and low-molecular-weight heparins: tolerance of a new recombinant hirudin.
Koch P; Münssinger T; Rupp-John C; Uhl K
J Am Acad Dermatol; 2000 Apr; 42(4):612-9. PubMed ID: 10727306
[TBL] [Abstract][Full Text] [Related]
5. Low molecular weight heparin-induced skin necrosis-a systematic review.
Handschin AE; Trentz O; Kock HJ; Wanner GA
Langenbecks Arch Surg; 2005 Jun; 390(3):249-54. PubMed ID: 15570433
[TBL] [Abstract][Full Text] [Related]
6. Association of heparin-induced skin lesions, intracutaneous tests, and heparin-induced IgG.
Harenberg J; Huhle G; Wang L; Hoffmann U; Bayerl C; Kerowgan M
Allergy; 1999 May; 54(5):473-7. PubMed ID: 10380778
[TBL] [Abstract][Full Text] [Related]
7. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight.
Grims RH; Weger W; Reiter H; Arbab E; Kränke B; Aberer W
Br J Dermatol; 2007 Sep; 157(3):514-7. PubMed ID: 17573880
[TBL] [Abstract][Full Text] [Related]
8. Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides.
Ludwig RJ; Schindewolf M; Alban S; Kaufmann R; Lindhoff-Last E; Boehncke WH
Thromb Haemost; 2005 Dec; 94(6):1265-9. PubMed ID: 16411404
[TBL] [Abstract][Full Text] [Related]
9. Hypersensitivity reactions to low molecular weight heparins: different patterns of cross-reactivity in 3 patients.
Juricic Nahal D; Cegec I; Erdeljic Turk V; Makar Ausperger K; Kraljickovic I; Simic I
Can J Physiol Pharmacol; 2018 Apr; 96(4):428-432. PubMed ID: 28977756
[TBL] [Abstract][Full Text] [Related]
10. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study.
Gaigl Z; Pfeuffer P; Raith P; Bröcker EB; Trautmann A
Br J Haematol; 2005 Feb; 128(3):389-92. PubMed ID: 15667543
[TBL] [Abstract][Full Text] [Related]
11. Incidence of hypersensitivity skin reactions in patients on full-dose low-molecular-weight heparins during pregnancy.
Schultinge L; Knol HM; Kluin-Nelemans HC; Erwich JJ; Meijer K
Neth J Med; 2013 Dec; 71(10):518-22. PubMed ID: 24394737
[TBL] [Abstract][Full Text] [Related]
12. Delayed-type hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux.
Koch P
Contact Dermatitis; 2003 Dec; 49(6):276-80. PubMed ID: 15025697
[TBL] [Abstract][Full Text] [Related]
13. Skin tests in patients with delayed and immediate hypersensitivity to heparins: A case series.
Tramontana M; Hansel K; Bianchi L; Agostinelli D; Stingeni L
Contact Dermatitis; 2019 Mar; 80(3):170-172. PubMed ID: 30450556
[No Abstract] [Full Text] [Related]
14. Low incidence of heparin-induced skin lesions in orthopedic surgery patients with low-molecular-weight heparins.
Schindewolf M; Paulik M; Kroll H; Kaufmann R; Wolter M; Boehncke WH; Lindhoff-Last E; Recke A; Ludwig RJ
Clin Exp Allergy; 2018 Aug; 48(8):1016-1024. PubMed ID: 29683226
[TBL] [Abstract][Full Text] [Related]
15. Delayed-Type Heparin Allergy: Intravenous Tolerance Despite Inflammatory Skin Reaction After Subcutaneous Injection.
Trautmann A; Grän F; Stoevesandt J
J Allergy Clin Immunol Pract; 2022 Nov; 10(11):2977-2983.e1. PubMed ID: 35788063
[TBL] [Abstract][Full Text] [Related]
16. The complex clinical picture of side effects to anticoagulation.
Trautmann A; Seitz CS
Med Clin North Am; 2010 Jul; 94(4):821-34, xii-iii. PubMed ID: 20609865
[TBL] [Abstract][Full Text] [Related]
17. Skin necrosis at the injection site induced by low-molecular-weight heparin: case report and review.
Santamaría A; Romaní J; Souto JC; López A; Mateo J; Fontcuberta J
Dermatology; 1998; 196(2):264-5. PubMed ID: 9568422
[TBL] [Abstract][Full Text] [Related]
18. Hypersensitivity reactions to heparins.
Gonzalez-Delgado P; Fernandez J
Curr Opin Allergy Clin Immunol; 2016 Aug; 16(4):315-22. PubMed ID: 27285488
[TBL] [Abstract][Full Text] [Related]
19. Tolerance of desirudin in a patient with generalized eczema after intravenous challenge with heparin and a delayed-type skin reaction to high and low molecular weight heparins and heparinoids.
Schiffner R; Glässl A; Landthaler M; Stolz W
Contact Dermatitis; 2000 Jan; 42(1):49. PubMed ID: 10644031
[No Abstract] [Full Text] [Related]
20. Heparin-induced recurrent anaphylaxis.
Berkun Y; Haviv YS; Schwartz LB; Shalit M
Clin Exp Allergy; 2004 Dec; 34(12):1916-8. PubMed ID: 15663568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
